Skip to main content
. 2023 May 1;13:1179689. doi: 10.3389/fcimb.2023.1179689

Figure 1.

Figure 1

The patients flowchart. (Anti-HBc, antibody to hepatitis B core antigen; HBV, hepatitis B virus; HCC, hepatocarcinoma; HCV, hepatitis C virus; ICIs, immune checkpoint inhibitors; TACE, transarterial chemoembolization; TKIs, tyrosine kinase inhibitors).